Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Merit Medical Systems, Inc.    MMSI

MERIT MEDICAL SYSTEMS, INC.

(MMSI)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2019 Guidance on February 26, 2019

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 09:26am EST

SOUTH JORDAN, Utah, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the fourth quarter and year ended December 31, 2018 and guidance for the year ending December 31, 2019, after the close of the stock market on Tuesday, February 26, 2019.

Merit will hold its investor conference call (conference ID 9186535) on the same day (Tuesday, February 26, 2019) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific).  The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656.  A live webcast will also be available for the conference call at merit.com.

ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 300 individuals. Merit employs approximately 5,800 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose and Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.

Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167  e-mail: awright@merit.com  Fax: (801) 253-1688

 

Merit Medical Systems, Inc. Logo


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERIT MEDICAL SYSTEMS, INC
02/12Merit Medical Systems to Announce Fourth Quarter and Year End Results and 2..
GL
01/11MERIT MEDICAL : Acquires Assets of Vascular Insights, LLC
PU
01/07Merit Medical to Present at Needham Growth Conference
GL
01/03Merit Medical Announces Appointment of Two New Directors
GL
2018MERIT MEDICAL SYSTEMS INC : Change in Directors or Principal Officers (form 8-K)
AQ
2018Merit Medical Acquires Assets of Vascular Insights, LLC
GL
2018MERIT MEDICAL : Ireland Wins Medtech Company of the Year Award 2018
AQ
2018MERIT MEDICAL : EmboCube embolization gelatin granted FDA approval for embolizat..
PU
2018MERIT MEDICAL SYSTEMS INC : Completion of Acquisition or Disposition of Assets, ..
AQ
2018Merit Medical Closes Cianna Medical, Inc. Deal
GL
More news
Financials ($)
Sales 2018 880 M
EBIT 2018 123 M
Net income 2018 47,4 M
Debt 2018 -
Yield 2018 -
P/E ratio 2018 67,63
P/E ratio 2019 43,50
Capi. / Sales 2018 3,72x
Capi. / Sales 2019 3,25x
Capitalization 3 268 M
Chart MERIT MEDICAL SYSTEMS, INC.
Duration : Period :
Merit Medical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERIT MEDICAL SYSTEMS, INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 70,2 $
Spread / Average Target 18%
EPS Revisions
Managers
NameTitle
Fred P. Lampropoulos Chairman, President & Chief Executive Officer
Ronald A. Frost Chief Operating Officer
Raul Parra Chief Financial Officer
Joseph Pierce Chief Information Officer
Jason Treft Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MERIT MEDICAL SYSTEMS, INC.6.79%3 268
COLOPLAST3.70%18 801
HENRY SCHEIN-20.54%9 511
AMPLIFON SPA16.30%4 177
CANTEL MEDICAL CORP.13.70%3 532
PATTERSON COMPANIES17.65%2 196